Boston Scientific (NYSE:BSX) said today it inked a deal worth up to $300 million to acquire Apama Medical and its radiofrequency balloon catheter system designed to treat atrial fibrillation. The deal includes an initial $175 million in cash up-front from Marlborough, Mass.-based Boston Scientific and an additional $125 million in contingent payments between 2018 and 2020 based on […]
UPDATE: Apama Medical raises $20m
Updated to include new information from Apama Medical Novel catheter ablation tech developer Apama Medical said it raised a total of $19.7 million, with $13.2 million coming from a closed Series C round and $6.5 million from a debt facility with Silicon Valley Bank. Apama Medical is developing novel ablation catheter technology to combine “the best elements […]
Novel AF cath developer Apama Medical raises $9m
Novel catheter ablation tech developer Apama Medical raised $9 million in a new round of equity financing, according to an SEC filing posted today. Apama Medical is developing novel ablation catheter technology to combine “the best elements of existing ablation technology while incorporating additional unique features to address gaps in current technology,” according to it’s […]
Cali startup Apama Medical lands $3.2M Series A-1
California startup Apama Medical raised $3.2 million in a Series A-1 financing round in support of a catheter-based technology that the company says is "vastly superior" in treatment of atrial fibrillation.
The company offered few details about the device in the press release or on its minimal website, but noted that it hopes to enter an atrial fibrillation mapping and ablation market that it expects to reach $2 billion by 2017.